THE U.S. FOOD AND DRUG ADMINISTRATION RECENTLY gave the green light to two groundbreaking treatments for sickle cell disease. One is Casgevy, which uses a gene-editing technique called CRISPR, and the other is Lyfgenia, a gene therapy.
As a medical student, I remember seeing a young woman wi...